Pathogenic variants in endoglin (ENG) and activin A receptor type II-like 1 (ACVRL1) genes are detected in approximately 85% of cases submitted to molecular diagnosis for clinical suspicion of HHT, causing HHT1 and HHT2, respectively (2, 7, 8). Here, ENG is linked to hereditary hemorrhagic telangiectasia.